STAAR Surgical Co
Uždarymo kaina
SektoriusSveikatos priežiūra
28.35 -1.29
Apžvalga
Akcijų kainos pasikeitimas
24 val.
Min
28.16
Max
28.47
Pajamos | 5.2M 5.2M |
|---|---|
Pardavimai | 36M 94M |
Pelnas, tenkantis vienai akcijai | 0.1 |
Pelno marža | 5.567 |
Darbuotojai | 921 |
EBITDA | 28M 20M |
Rekomendacijos | Neutralu |
|---|---|
12 mėnesių prognozė | +10.43% upside |
Kitas uždarbis | 2026-08-05 |
|---|
Rinkos kapitalizacija | 106M 1.5B |
|---|---|
Ankstesnė atidarymo kaina | 29.64 |
Ankstesnė uždarymo kaina | 28.35 |
Naujienos nuotaikos
By Acuity
38%
62%
102 / 342 reitingas Healthcare
STAAR Surgical Co Grafikas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
Apie bendrovę STAAR Surgical Co
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.